Quintiles has officially opened its new European headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

Lord Howe, Parliamentary Under-Secretary of State for Health commented: "Having Quintiles open their European headquarters in Reading is excellent news. Their decision shows that the UK is an attractive environment for international pharmaceutical companies to invest in.”

“The Government is committed to promoting the development of new, innovative treatments for NHS patients and I look forward to seeing the results of the exciting work that Quintiles will carry out at Reading,” said Howe.

Quintiles founder, chairman and chief executive Officer Dennis Gillings, CBE, stressed the continued importance of Europe, particularly the UK, in the global market, and Quintiles’ investment in innovation and quality across the spectrum of drug development and commercialization.

Gillings said: “I am proud to extend our strategic commitment to Europe, Middle East and Africa with this regional headquarters investment.  With such a wealth of scientific, medical and commercial expertise in the UK, the move has encouraged more cross-discipline collaboration to better serve Quintiles’ customers and power them forward in the fast-morphing world of biopharma.”